Matches in SemOpenAlex for { <https://semopenalex.org/work/W281330656> ?p ?o ?g. }
- W281330656 endingPage "15769" @default.
- W281330656 startingPage "15758" @default.
- W281330656 abstract "The cysteine protease cathepsin L (CTSL) is often thought to act as a tumor promoter by enhancing tumor progression and metastasis. This goes along with increased CTSL activity in various tumor entities; however, the mechanisms leading to high CTSL levels are incompletely understood. With the help of the polyoma middle T oncogene driven breast cancer mouse model expressing a human CTSL genomic transgene, we show that CTSL indeed promotes breast cancer metastasis to the lung. During tumor formation and progression high expression levels of CTSL are maintained by enduring translation of CTSL mRNA. Interestingly, human breast cancer specimens expressed the same pattern of 5′ untranslated region (UTR) splice variants as the transgenic mice and the human cancer cell line MDA-MB 321. By polyribosome profiling of tumor tissues and human breast cancer cells, we observe an intrinsic resistance of CTSL to stress-induced shutdown of translation. This ability can be attributed to all 5′ UTR variants of CTSL and is not dependent on a previously described internal ribosomal entry site motif. In conclusion, we provide in vivo functional evidence for overexpressed CTSL as a promoter of lung metastasis, whereas high CTSL levels are maintained during tumor progression due to stress-resistant mRNA translation.Background:Translational regulation might underlie the high expression levels of the protease cathepsin L (CTSL) associated with poor breast cancer prognosis.Results:Translation of CTSL mRNA is highly stress-resistant and promotes metastasis of murine breast cancer.Conclusion:CTSL mRNA circumvents translational shutdown in cancer-associated stress conditions.Significance:High expression of a metastasis promoting protease is maintained by translational regulation. The cysteine protease cathepsin L (CTSL) is often thought to act as a tumor promoter by enhancing tumor progression and metastasis. This goes along with increased CTSL activity in various tumor entities; however, the mechanisms leading to high CTSL levels are incompletely understood. With the help of the polyoma middle T oncogene driven breast cancer mouse model expressing a human CTSL genomic transgene, we show that CTSL indeed promotes breast cancer metastasis to the lung. During tumor formation and progression high expression levels of CTSL are maintained by enduring translation of CTSL mRNA. Interestingly, human breast cancer specimens expressed the same pattern of 5′ untranslated region (UTR) splice variants as the transgenic mice and the human cancer cell line MDA-MB 321. By polyribosome profiling of tumor tissues and human breast cancer cells, we observe an intrinsic resistance of CTSL to stress-induced shutdown of translation. This ability can be attributed to all 5′ UTR variants of CTSL and is not dependent on a previously described internal ribosomal entry site motif. In conclusion, we provide in vivo functional evidence for overexpressed CTSL as a promoter of lung metastasis, whereas high CTSL levels are maintained during tumor progression due to stress-resistant mRNA translation. Translational regulation might underlie the high expression levels of the protease cathepsin L (CTSL) associated with poor breast cancer prognosis. Translation of CTSL mRNA is highly stress-resistant and promotes metastasis of murine breast cancer. CTSL mRNA circumvents translational shutdown in cancer-associated stress conditions." @default.
- W281330656 created "2016-06-24" @default.
- W281330656 creator A5011116789 @default.
- W281330656 creator A5017517167 @default.
- W281330656 creator A5027534198 @default.
- W281330656 creator A5050081903 @default.
- W281330656 creator A5057117881 @default.
- W281330656 creator A5061376363 @default.
- W281330656 creator A5074537923 @default.
- W281330656 creator A5084216669 @default.
- W281330656 creator A5087251180 @default.
- W281330656 date "2015-06-01" @default.
- W281330656 modified "2023-10-14" @default.
- W281330656 title "Stress-resistant Translation of Cathepsin L mRNA in Breast Cancer Progression" @default.
- W281330656 cites W1964221844 @default.
- W281330656 cites W1965395430 @default.
- W281330656 cites W1972125241 @default.
- W281330656 cites W1972300130 @default.
- W281330656 cites W1980239925 @default.
- W281330656 cites W1982592578 @default.
- W281330656 cites W1983365254 @default.
- W281330656 cites W1987792229 @default.
- W281330656 cites W1989415481 @default.
- W281330656 cites W1990075422 @default.
- W281330656 cites W1997104566 @default.
- W281330656 cites W1997827566 @default.
- W281330656 cites W2000614562 @default.
- W281330656 cites W2001008924 @default.
- W281330656 cites W2009776996 @default.
- W281330656 cites W2012119308 @default.
- W281330656 cites W2014361616 @default.
- W281330656 cites W2016107719 @default.
- W281330656 cites W2018634450 @default.
- W281330656 cites W2025339895 @default.
- W281330656 cites W2037030307 @default.
- W281330656 cites W2044821390 @default.
- W281330656 cites W2045773985 @default.
- W281330656 cites W2055903162 @default.
- W281330656 cites W2059544008 @default.
- W281330656 cites W2064634789 @default.
- W281330656 cites W2082833890 @default.
- W281330656 cites W2083022144 @default.
- W281330656 cites W2083323375 @default.
- W281330656 cites W2089258206 @default.
- W281330656 cites W2089716875 @default.
- W281330656 cites W2090985686 @default.
- W281330656 cites W2093890995 @default.
- W281330656 cites W2117209223 @default.
- W281330656 cites W2124727440 @default.
- W281330656 cites W2130165454 @default.
- W281330656 cites W2135301845 @default.
- W281330656 cites W2143613937 @default.
- W281330656 cites W2159312214 @default.
- W281330656 cites W2165848665 @default.
- W281330656 cites W2171744625 @default.
- W281330656 cites W2259897691 @default.
- W281330656 doi "https://doi.org/10.1074/jbc.m114.624353" @default.
- W281330656 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4505485" @default.
- W281330656 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25957406" @default.
- W281330656 hasPublicationYear "2015" @default.
- W281330656 type Work @default.
- W281330656 sameAs 281330656 @default.
- W281330656 citedByCount "21" @default.
- W281330656 countsByYear W2813306562016 @default.
- W281330656 countsByYear W2813306562017 @default.
- W281330656 countsByYear W2813306562019 @default.
- W281330656 countsByYear W2813306562020 @default.
- W281330656 countsByYear W2813306562021 @default.
- W281330656 countsByYear W2813306562022 @default.
- W281330656 countsByYear W2813306562023 @default.
- W281330656 crossrefType "journal-article" @default.
- W281330656 hasAuthorship W281330656A5011116789 @default.
- W281330656 hasAuthorship W281330656A5017517167 @default.
- W281330656 hasAuthorship W281330656A5027534198 @default.
- W281330656 hasAuthorship W281330656A5050081903 @default.
- W281330656 hasAuthorship W281330656A5057117881 @default.
- W281330656 hasAuthorship W281330656A5061376363 @default.
- W281330656 hasAuthorship W281330656A5074537923 @default.
- W281330656 hasAuthorship W281330656A5084216669 @default.
- W281330656 hasAuthorship W281330656A5087251180 @default.
- W281330656 hasBestOaLocation W2813306561 @default.
- W281330656 hasConcept C102230213 @default.
- W281330656 hasConcept C104317684 @default.
- W281330656 hasConcept C105580179 @default.
- W281330656 hasConcept C121608353 @default.
- W281330656 hasConcept C153911025 @default.
- W281330656 hasConcept C167844969 @default.
- W281330656 hasConcept C181199279 @default.
- W281330656 hasConcept C2779013556 @default.
- W281330656 hasConcept C2779256057 @default.
- W281330656 hasConcept C2780034444 @default.
- W281330656 hasConcept C502942594 @default.
- W281330656 hasConcept C530470458 @default.
- W281330656 hasConcept C54355233 @default.
- W281330656 hasConcept C55493867 @default.
- W281330656 hasConcept C86803240 @default.
- W281330656 hasConcept C89604277 @default.
- W281330656 hasConceptScore W281330656C102230213 @default.